229 related articles for article (PubMed ID: 8543978)
1. In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-111-DTPA-Arg1]substance P.
Breeman WA; VanHagen MP; Visser-Wisselaar HA; van der Pluijm ME; Koper JW; Setyono-Han B; Bakker WH; Kwekkeboom DJ; Hazenberg MP; Lamberts SW; Visser TJ; Krenning EP
J Nucl Med; 1996 Jan; 37(1):108-17. PubMed ID: 8543978
[TBL] [Abstract][Full Text] [Related]
2. Visualization of the thymus by substance P receptor scintigraphy in man.
van Hagen PM; Breeman WA; Reubi JC; Postema PT; van den Anker-Lugtenburg PJ; Kwekkeboom DJ; Laissue J; Waser B; Lamberts SW; Visser TJ; Krenning EP
Eur J Nucl Med; 1996 Nov; 23(11):1508-13. PubMed ID: 8854850
[TBL] [Abstract][Full Text] [Related]
3. A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
Breeman WA; Hofland LJ; van der Pluijm M; van Koetsveld PM; de Jong M; Setyono-Han B; Bakker WH; Kwekkeboom DJ; Visser TJ; Lamberts SW
Eur J Nucl Med; 1994 Apr; 21(4):328-35. PubMed ID: 7911760
[TBL] [Abstract][Full Text] [Related]
4. In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats.
Bakker WH; Krenning EP; Reubi JC; Breeman WA; Setyono-Han B; de Jong M; Kooij PP; Bruns C; van Hagen PM; Marbach P
Life Sci; 1991; 49(22):1593-601. PubMed ID: 1658516
[TBL] [Abstract][Full Text] [Related]
5. Binding characteristics of [125I]Bolton-Hunter [Sar9,Met(O2)11]substance P, a new selective radioligand for the NK1 receptor.
Lew R; Geraghty DP; Drapeau G; Regoli D; Burcher E
Eur J Pharmacol; 1990 Aug; 184(1):97-108. PubMed ID: 1698645
[TBL] [Abstract][Full Text] [Related]
6. Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.
de Jong M; Bakker WH; Bernard BF; Valkema R; Kwekkeboom DJ; Reubi JC; Srinivasan A; Schmidt M; Krenning EP
J Nucl Med; 1999 Dec; 40(12):2081-7. PubMed ID: 10616889
[TBL] [Abstract][Full Text] [Related]
7. Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy.
Bernard BF; Krenning E; Breeman WA; Visser TJ; Bakker WH; Srinivasan A; de Jong M
Nucl Med Commun; 2000 Nov; 21(11):1079-85. PubMed ID: 11192715
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of copper-64-octreotide conjugates.
Anderson CJ; Pajeau TS; Edwards WB; Sherman EL; Rogers BE; Welch MJ
J Nucl Med; 1995 Dec; 36(12):2315-25. PubMed ID: 8523125
[TBL] [Abstract][Full Text] [Related]
9. [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation.
Bakker WH; Albert R; Bruns C; Breeman WA; Hofland LJ; Marbach P; Pless J; Pralet D; Stolz B; Koper JW
Life Sci; 1991; 49(22):1583-91. PubMed ID: 1658515
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biodistribution and imaging properties of indium-111-DTPA-paclitaxel in mice bearing mammary tumors.
Li C; Yu DF; Inoue T; Yang DJ; Tansey W; Liu CW; Milas L; Hunter NR; Kim EE; Wallace S
J Nucl Med; 1997 Jul; 38(7):1042-7. PubMed ID: 9225788
[TBL] [Abstract][Full Text] [Related]
11. Substance P receptor on parotid cell membranes.
Liang T; Cascieri MA
J Neurosci; 1981 Oct; 1(10):1133-41. PubMed ID: 6169814
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo.
de Jong M; Rolleman EJ; Bernard BF; Visser TJ; Bakker WH; Breeman WA; Krenning EP
J Nucl Med; 1996 Aug; 37(8):1388-92. PubMed ID: 8708781
[TBL] [Abstract][Full Text] [Related]
13. Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy.
Breeman WA; De Jong M; Bernard BF; Kwekkeboom DJ; Srinivasan A; van der Pluijm ME; Hofland LJ; Visser TJ; Krenning EP
Int J Cancer; 1999 Nov; 83(5):657-63. PubMed ID: 10521803
[TBL] [Abstract][Full Text] [Related]
14. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
Breeman WA; de Jong M; Erion JL; Bugaj JE; Srinivasan A; Bernard BF; Kwekkeboom DJ; Visser TJ; Krenning EP
J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515
[TBL] [Abstract][Full Text] [Related]
15. Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes.
Duncan JR; Stephenson MT; Wu HP; Anderson CJ
Cancer Res; 1997 Feb; 57(4):659-71. PubMed ID: 9044843
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides.
Vallabhajosula S; Moyer BR; Lister-James J; McBride BJ; Lipszyc H; Lee H; Bastidas D; Dean RT
J Nucl Med; 1996 Jun; 37(6):1016-22. PubMed ID: 8683294
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.
Krenning EP; Bakker WH; Kooij PP; Breeman WA; Oei HY; de Jong M; Reubi JC; Visser TJ; Bruns C; Kwekkeboom DJ
J Nucl Med; 1992 May; 33(5):652-8. PubMed ID: 1349039
[TBL] [Abstract][Full Text] [Related]
18. Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo.
Reubi JC; Waser B; Schaer JC; Laederach U; Erion J; Srinivasan A; Schmidt MA; Bugaj JE
Eur J Nucl Med; 1998 May; 25(5):481-90. PubMed ID: 9575243
[TBL] [Abstract][Full Text] [Related]
19. Evaluation in vitro and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy.
de Jong M; Breeman WA; Bernard BF; Rolleman EJ; Hofland LJ; Visser TJ; Setyono-Han B; Bakker WH; van der Pluijm ME; Krenning EP
Eur J Nucl Med; 1995 Jul; 22(7):608-16. PubMed ID: 7498221
[TBL] [Abstract][Full Text] [Related]
20. Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer.
Müller C; Schibli R; Krenning EP; de Jong M
J Nucl Med; 2008 Apr; 49(4):623-9. PubMed ID: 18344429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]